P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
<h4>Background</h4>Duchenne muscular dystrophy (DMD) is the most common inherited muscle disease, leading to severe disability and death in young men. Death is caused by the progressive degeneration of striated muscles aggravated by sterile inflammation. The pleiotropic effects of the mu...
Main Authors: | Anthony Sinadinos, Christopher N J Young, Rasha Al-Khalidi, Anna Teti, Paweł Kalinski, Shafini Mohamad, Léonore Floriot, Tiphaine Henry, Gianluca Tozzi, Taiwen Jiang, Olivier Wurtz, Alexis Lefebvre, Mikhail Shugay, Jie Tong, David Vaudry, Stephen Arkle, Jean-Claude doRego, Dariusz C Górecki |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-10-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1001888 |
Similar Items
-
P2RX7 purinoceptor as a therapeutic target in Duchenne muscular dystrophy
by: Al-khalidi, Rasha
Published: (2017) -
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
by: Rasha Al-Khalidi, et al.
Published: (2018-04-01) -
Impact of P2RX7 purinoceptor ablation on the morphometric, mechanical and tissue properties in the murine model of Duchenne muscular dystrophy
by: Binti Mohamad, Noor Shafini
Published: (2016) -
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
by: Chris N. J. Young, et al.
Published: (2018-06-01) -
Role for ovarian hormones in purinoceptor-dependent natriuresis
by: Eman Y. Gohar, et al.
Published: (2020-09-01)